This Vaccine Policy Debate Is Backwards—Here’s What Actually Needs Fixing
A breakdown of the March 6, 2026 Siri letter, ACIP restructuring, and why the real issue in vaccine policy is compensation—not liability.
A fundamental shift in U.S. vaccine policy is underway, driven by the March 6, 2026 letter from Aaron Siri and ICAN and recent changes to the Advisory Committee on Immunization Practices (ACIP) under HHS. While these developments are being framed as efforts to improve vaccine safety and transparency, the reality is far more consequential. This is about control over vaccine recommendations, liability protections, and, most importantly, whether individuals injured by vaccines have access to meaningful compensation. As a vaccine injury attorney who litigates these cases every day, I can say with certainty: the current debate is not focused on the right problem.
The Conversation Is Focused on the Wrong Issue
The current discourse surrounding vaccine policy reform is built on a flawed premise. The suggestion that the system’s core problem lies in liability protections or the existence of the PREP Act reflects a misunderstanding of how vaccine injury claims actually function in practice. The PREP Act itself is not the issue. The issue is the compensation structure that accompanies it.
Under the current framework, individuals alleging injury from COVID vaccines are routed into a system that does not operate as a true compensation program. It is limited in scope, restrictive in eligibility, and lacks the procedural safeguards that define a functioning legal system. The result is not merely inefficiency—it is exclusion. Many individuals with legitimate claims are unable to recover at all, not because their claims lack merit, but because the system is not designed to accommodate them.
A meaningful reform effort would start by acknowledging this reality. The focus should not be on dismantling liability protections, but on ensuring that those protections are paired with a compensation system that works.
What the March 6, 2026 Letter Actually Seeks to Do
The March 6, 2026 letter proposes sweeping changes to the structure of vaccine regulation in the United States. While framed as an effort to improve safety and transparency, its substance reflects a broader attempt to reshape how vaccines are evaluated, recommended, and regulated across federal agencies.
Among its proposals are the elimination of routine vaccine recommendations in favor of individualized decision-making, the imposition of more burdensome clinical trial requirements, and structural changes affecting how agencies collect, analyze, and disseminate vaccine-related data. It also raises the issue of liability protections in a way that suggests dismantling existing frameworks rather than improving the systems that operate alongside them.
These proposals are not incremental. They represent a fundamental shift away from a centralized, science-driven approach to vaccine policy and toward a more fragmented and legally uncertain framework.
The Problem with “Shared Decision-Making” as Policy
One of the most consequential proposals in the current reform discussion is the move from routine vaccine recommendations to a model of “shared clinical decision-making.” While this concept may appear reasonable in isolation, its implications are significant.
Routine recommendations establish a clear standard of care. They provide consistency across providers, ensure uniform insurance coverage, and create a stable legal framework within which both physicians and patients operate. Shared decision-making, by contrast, removes that default. It shifts responsibility to individual providers and patients without providing a consistent baseline.
This shift introduces variability into medical practice, complicates reimbursement structures, and creates ambiguity in liability. From a legal perspective, it weakens the predictability that underpins both clinical decision-making and compensation systems. It is not a neutral change. It is a structural one, with consequences that extend well beyond individual patient interactions.
ACIP Is Not Just Advisory—It Is Foundational
The restructuring of ACIP must be understood in this context. ACIP is not simply an advisory body offering non-binding guidance. Its recommendations are embedded in federal law and have direct consequences for insurance coverage, public health policy, and liability protections.
When ACIP issues a recommendation, that recommendation determines what insurers must cover, what constitutes standard medical practice, and which vaccines fall within the Vaccine Injury Compensation Program. In effect, ACIP serves as the gateway through which vaccines enter the broader legal and regulatory framework.
Changes to ACIP, therefore, are not merely procedural. They affect the integrity of the entire system.
The Breakdown in Expertise and Process
The recent restructuring of ACIP raises serious concerns about both expertise and process. Historically, ACIP has been composed of individuals with specialized knowledge in immunization practices, vaccine safety, epidemiology, and clinical research. That expertise is not incidental; it is essential to the committee’s function.
The current composition reflects a departure from that model. While many of the appointed individuals are accomplished professionals, a significant number do not have meaningful experience in vaccines or immunization policy. This creates a disconnect between the committee’s mandate and its ability to fulfill that mandate effectively.
Equally concerning is the process by which these appointments were made. The longstanding procedures designed to ensure balance, transparency, and rigorous vetting were not followed. When both expertise and process are compromised, the legitimacy of the resulting recommendations is necessarily called into question.
The Real Difference: CICP vs. VICP
The most important issue in this entire debate is the distinction between the current compensation system and the one that should be in place.
The CICP does not function as a true compensation program. It does not allow recovery for pain and suffering or attorneys’ fees. It imposes caps on medical expenses and lost wages. It requires claims to be filed within one year of vaccination, a limitation that excludes many otherwise valid claims. Most critically, it lacks an independent adjudicatory structure. The same agency that administers the program effectively decides the outcome, and there is no meaningful right to appeal to an independent court.
The VICP operates in a fundamentally different way. It provides compensation for pain and suffering, lost wages, and both past and future medical expenses. It allows for recovery of attorneys’ fees, enabling individuals to pursue claims with proper representation. It provides a three-year statute of limitations, recognizing the realities of medical diagnosis and progression. Most importantly, it is adjudicated in an independent court system with special masters and a defined appellate process.
This is the difference between a system that exists in name and one that functions in practice.
What Real Reform Would Look Like
If the goal is to improve vaccine policy, the path forward is clear. Liability protections should remain in place to ensure continued vaccine development and distribution. At the same time, vaccines covered by those protections must be paired with a compensation system that provides meaningful recovery for those who are injured.
That means moving COVID vaccines into the VICP.
This approach preserves the stability of the system while addressing its most significant failure. It aligns legal protection with legal responsibility and ensures that individuals are not left without recourse.
Conclusion
The current debate over vaccine policy reform is not about safety in the way it is being presented. It is about structure, control, and the allocation of legal rights within the system. Efforts to redefine recommendation standards, restructure advisory bodies, and alter liability frameworks risk destabilizing a system that, while imperfect, has a clear and functional core.
The focus should not be on dismantling that system. It should be on fixing the part that does not work.
For those who represent injured individuals, the issue is not theoretical. It is practical and immediate. A system that fails to compensate those it was designed to protect is not a system in need of refinement. It is a system in need of correction.